<style face="normal" font="default" size="100%">Preparation of labeled aromatic amino acids via late-stage 18F-fluorination of chiral nickel and copper complexes</style>

neumaier.enl

EndNote

1

1

17

<style face="normal" font="default" size="100%">Preparation of labeled aromatic amino acids via late-stage 18F-fluorination of chiral nickel and copper complexes</style>

neumaier.enl

EndNote

2

2

17

<style face="normal" font="default" size="100%">In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer’s Disease</style>

neumaier.enl

EndNote

11

11

17

<style face="normal" font="default" size="100%">AI-based identification of therapeutic agents targeting GPCRs: introducing ligand type classifiers and systems biology</style>

neumaier.enl

EndNote

3

3

17

<style face="normal" font="default" size="100%">Networks of tau distribution in Alzheimer’s disease</style>

neumaier.enl

EndNote

4

4

17

<style face="normal" font="default" size="100%">[18F]ALX5406: A Brain-Penetrating Prodrug for GlyT1-Specific PET Imaging</style>

neumaier.enl

EndNote

5

5

17

<style face="normal" font="default" size="100%">Rapid 18F-labeling via Pd-catalyzed S-arylation in aqueous medium</style>

neumaier.enl

EndNote

6

6

17

<style face="normal" font="default" size="100%">Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer’s disease</style>

neumaier.enl

EndNote

12

12

17

<style face="normal" font="default" size="100%">Convenient PET-tracer production via SuFEx (18)F-fluorination of nanomolar precursor amounts</style>

neumaier.enl

EndNote

8

8

17

<style face="normal" font="default" size="100%">Discovery of <sup>18</sup>F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions</style>